Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Blinded, Randomized Study of Gabapentin (Neurontin®) and Gabapentin Enacarbil (Horizant™) in Restless Leg Syndrome

NCT02117076 is registered in ClinicalTrials.gov with Theresa Zesiewicz, MD as lead sponsor.

NCT NCT02117076
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02117076 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Blinded, Randomized Study of Gabapentin (Neurontin®) and Gabapentin Enacarbil (Horizant™) in Restless Leg Syndrome
Lead sponsor
Theresa Zesiewicz, MD
Phase
Phase 4
Overall status
Terminated
Start date
April 30, 2014
Completion date
June 30, 2016
Enrollment
5 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

restless leg syndrome